Results 171 to 180 of about 2,979 (199)

Approval: Cariprazine

The Brown University Psychopharmacology Update, 2023
openaire   +1 more source

Mini Review on Cariprazine: A Promising Antipsychotic Agent

CNS and Neurological Disorders - Drug Targets, 2023
Ashish D Patel, Tushar Bambharoliya, Darshini Patel   +2 more
exaly  

Cariprazine in the Treatment of Bipolar Disorder: A Systematic Review and Meta-Analysis

Bipolar Disorders, 2020
Jairo Vinicius Pinto, Trisha Chakrabarty, Daniel Vigo   +2 more
exaly  

Cognitive Effects of Lurasidone and Cariprazine: A Mini Systematic Review

Current Neuropharmacology, 2023
Natascia Brondino, Vincenzo Arienti, Miriam Olivola   +2 more
exaly  

Cariprazine Versus Risperidone Monotherapy for Treatment of Predominant Negative Symptoms in Patients With Schizophrenia: A Randomised, Double-Blind, Controlled Trial

Lancet, The, 2017
Pal Czobor, István Bitter, Stephen R Marder   +2 more
exaly  

Efficacy and Safety of Cariprazine in Bipolar I Depression: A Double-Blind, Placebo-Controlled Phase 3 Study

Bipolar Disorders, 2020
Mauricio Tohen, Trisha Suppes, Joseph R Calabrese   +2 more
exaly  

Long-Term Effects of Cariprazine Exposure on Dopamine Receptor Subtypes

CNS Spectrums, 2014
Frank I Tarazi, Nika Adham, István Gyertyán   +2 more
exaly  

The polarity index of cariprazine

European Neuropsychopharmacology
Dina Popovic, Eduard Vieta
openaire   +2 more sources

Brexpiprazole and Cariprazine: Distinguishing Two New Atypical Antipsychotics From the Original Dopamine Stabilizer Aripiprazole

Therapeutic Advances in Psychopharmacology, 2017
Thomas L Schwartz
exaly  

Cariprazine release formulations

2021
HUI YU, YUAN KEVIN, ZHANG TIAN
openaire   +2 more sources